The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Diffuse Midline Gliomas with Histone H3‐K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
Open accessAbstract
Somatic mutations of the H3F3A and HIST1H3B genes encoding the histone H3 variants, H3.3 and H3.1, were recently identified in high‐grade gliomas arising in the thalamus, pons and spinal cord of children and young adults. However, the complete range of patients and locations in which these tumors arise, as well as the morphologic spectrum and associated genetic alterations remain undefined. Here, we describe a series of 47 diffuse midline gliomas with histone H3‐K27M mutation. The 25 male and 22 female patients ranged in age from 2 to 65 years (median = 14). Tumors were centered not only in the pons, thalamus, and spinal cord, but also in the third ventricle, hypothalamus, pineal region and cerebellum. Patients with pontine tumors were younger (median = 7 years) than those with thalamic (median = 24 years) or spinal (median = 25 years) tumors. A wide morphologic spectrum was encountered including gliomas with giant cells, epithelioid and rhabdoid cells, primitive neuroectodermal tumor (PNET)‐like foci, neuropil‐like islands, pilomyxoid features, ependymal‐like areas, sarcomatous transformation, ganglionic differentiation and pleomorphic xanthoastrocytoma (PXA)‐like areas. In this series, histone H3‐K27M mutation was mutually exclusive with IDH1 mutation and EGFR amplification, rarely co‐occurred with BRAF‐V600E mutation, and was commonly associated with p53 overexpression, ATRX loss (except in pontine gliomas), and monosomy 10.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Sturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.-A., Jones, D. T. W., Konermann, C., Pfaff, E., Tönjes, M., Sill, M., Bender, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.024 · Cited by 1,828
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Lewis, P. W., Müller, M. M., Koletsky, M. S., Cordero, F., Lin, S., Banaszynski, L. A., Garcia, B. A., Muir, T. W., Becher, O. J., & Allis, C. D. (2013) · Science · doi:10.1126/science.1232245 · Cited by 1,345 · cited 1×
“Investigation has shown that this K27M mutation alters an important site of post-translational modification in the histone H3 variants and leads to altered DNA methylation and gene expression profiles thought to drive gliomagenesis (3, 7, 15, 21, 26).”
Backgroundthe St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2014) · Nature Genetics · doi:10.1038/ng.2938 · Cited by 1,105
Khuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., Liu, X.-Y., Fontebasso, A. M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0998-0 · Cited by 1,028 · cited 3×
“In particular, these tumors often also have TP53 and ATRX mutations but do not have IDH1 mutation (19, 25, 26).”
BackgroundBender, S., Tang, Y., Lindroth, A. M., Hovestadt, V., Jones, D. T. W., Kool, M., Zapatka, M., Northcott, P. A., Sturm, D., Wang, W., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.006 · Cited by 818
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
Chan, K.-M., Fang, D., Gan, H., Hashizume, R., Yu, C., Schroeder, M., Gupta, N., Mueller, S., James, C. D., Jenkins, R., et al. (2013) · Genes & Development · doi:10.1101/gad.217778.113 · Cited by 707
Self-citationFunctionally defined therapeutic targets in diffuse intrinsic pontine glioma
Grasso, C. S., Tang, Y., Truffaux, N., Berlow, N. E., Liu, L., Debily, M.-A., Quist, M. J., Davis, L. E., Huang, E. C., Woo, P. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3855 · Cited by 687
Buczkowicz, P., Hoeman, C., Rakopoulos, P., Pajovic, S., Letourneau, L., Dzamba, M., Morrison, A., Lewis, P., Bouffet, E., Bartels, U., et al. (2014) · Nature Genetics · doi:10.1038/ng.2936 · Cited by 647
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Taylor, K. R., Mackay, A., Truffaux, N., Butterfield, Y. S., Morozova, O., Philippe, C., Castel, D., Grasso, C. S., Vinci, M., Carvalho, D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2925 · Cited by 517
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Hashizume, R., Andor, N., Ihara, Y., Lerner, R., Gan, H., Chen, X., Fang, D., Huang, X., Tom, M. W., Ngo, V., et al. (2014) · Nature Medicine · doi:10.1038/nm.3716 · Cited by 476
Self-citationRecurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Fontebasso, A. M., Papillon-Cavanagh, S., Schwartzentruber, J., Nikbakht, H., Gerges, N., Fiset, P.-O., Bechet, D., Faury, D., De Jay, N., Ramkissoon, L. A., et al. (2014) · Nature Genetics · doi:10.1038/ng.2950 · Cited by 465
Self-citationKorshunov, A., Ryzhova, M., Hovestadt, V., Bender, S., Sturm, D., Capper, D., Meyer, J., Schrimpf, D., Kool, M., Northcott, P. A., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1405-4 · Cited by 350
Self-citationBuczkowicz, P., Bartels, U., Bouffet, E., Becher, O., & Hawkins, C. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1319-6 · Cited by 350
Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling
Herz, H.-M., Morgan, M., Gao, X., Jackson, J., Rickels, R., Swanson, S. K., Florens, L., Washburn, M. P., Eissenberg, J. C., & Shilatifard, A. (2014) · Science · doi:10.1126/science.1255104 · Cited by 199
H3F3A K27M mutations in thalamic gliomas from young adult patients
Aihara, K., Mukasa, A., Gotoh, K., Saito, K., Nagae, G., Tsuji, S., Tatsuno, K., Yamamoto, S., Takayanagi, S., Narita, Y., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not144 · Cited by 199
Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas
Zhang, L., Chen, L. H., Wan, H., Yang, R., Wang, Z., Feng, J., Yang, S., Jones, S., Wang, S., Zhou, W., et al. (2014) · Nature Genetics · doi:10.1038/ng.2995 · Cited by 187
Venneti, S., Santi, M., Felicella, M. M., Yarilin, D. A., Phillips, J. J., Sullivan, L. M., Martínez, D., Perry, A., Lewis, P. W., Thompson, C. B., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1338-3 · Cited by 156
Self-citationH3F3A K27M Mutation in Pediatric CNS Tumors
Gielen, G. H., Gessi, M., Hammes, J., Kramm, C. M., Waha, A., & Pietsch, T. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpabohbc33fvmo · Cited by 145
Béchet, D., Gielen, G. H., Korshunov, A., Pfister, S. M., Rousso, C., Faury, D., Fiset, P., Benlimame, N., Lewis, P. W., Lü, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1337-4 · Cited by 144
Feng, J., Hao, S., Pan, C., Wang, Y., Wu, Z., Zhang, J., Yan, H., Zhang, L., & Wan, H. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.07.002 · Cited by 123
Gone FISHing: Clinical Lessons Learned in Brain Tumor Molecular Diagnostics over the Last Decade
Horbinski, C., Miller, C. R., & Perry, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00453.x · Cited by 118
Self-citationBroniscer, A., Tatevossian, R., Sabin, N. D., Klimo, P. D., Dalton, J., Lee, R. P., Gajjar, A. J., & Ellison, D. W. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12093 · Cited by 114
Gessi, M., Gielen, G. H., Dreschmann, V., Waha, A., & Pietsch, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1463-7 · Cited by 108
Molecular analysis of diffuse intrinsic brainstem gliomas in adults
Reyes-Botero, G., Giry, M., Mokhtari, K., Labussière, M., Idbaïh, A., Delattre, J., Laigle–Donadey, F., & Sanson, M. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1312-2 · Cited by 91
Unique Molecular Characteristics of Radiation-Induced Glioblastoma
Donson, A. M., Erwin, N. S., Kleinschmidt-DeMasters, B. K., Madden, J. R., Addo‐Yobo, S. O., & Foreman, N. K. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181257190 · Cited by 66
Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma
Hochart, A., Escande, F., Rocourt, N., Grill, J., Koubi-Pick, V., Beaujot, J., Meignan, S., Vinchon, M., Maurage, C., & Leblond, P. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.184 · Cited by 63
Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours
Nguyễn, A. T., Colin, C., Nanni‐Metellus, I., Padovani, L., Maurage, C., Varlet, P., Miquel, C., Uro‐Coste, E., Godfraind, C., Lechapt, E., et al. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12196 · Cited by 51
Huse, J. T., Nafa, K., Shukla, N. N., Kastenhuber, E. R., Lavi, E., Hedvat, C. V., Ladanyi, M., & Rosenblum, M. K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0855-6 · Cited by 16
Cited by
WHO 2016 Classification of gliomas
Wesseling, P., & Capper, D. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12432 · Cited by 795
Pediatric low-grade glioma in the era of molecular diagnostics
Ryall, S., Tabori, U., & Hawkins, C. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00902-z · Cited by 351
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management
Sturm, D., Pfister, S. M., & Jones, D. T. W. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.0242 · Cited by 339
Karremann, M., Gielen, G. H., Hoffmann, M., Wiese, M., Colditz, N., Warmuth-Metz, M., Bison, B., Claviez, A., van Vuurden, D. G., von Bueren, A. O., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/nox149 · Cited by 293
Characteristics of H3 K27M-mutant gliomas in adults
Meyronet, D., Esteban-Mader, M., Bonnet, C., Joly, M.-O., Uro-Coste, E., Amiel-Benouaich, A., Forest, F., Rousselot-Denis, C., Burel-Vandenbos, F., Bourg, V., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now274 · Cited by 279
Metadata
- Authors
- Solomon, D. A., Wood, M. D., Tihan, T., Bollen, A. W., Gupta, N., Phillips, J. J. J., & Perry, A.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2015-12-14
- Volume
- 26
- Issue
- 5
- Pages
- 569-580
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W1882182045
- Cited by
- 433
- References
- 30
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.